Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![WhatMarketMind Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1869290335937105920.png) WhatMarketMinds [@WhatMarketMind](/creator/twitter/WhatMarketMind) on x 1097 followers
Created: 2025-06-25 12:54:37 UTC


$A 20250529-Wells Fargo-Agilent Technologies, Inc (A) Key Takeaways from 2Q25
$PATH 20250529-Wells Fargo-UiPath, Inc (PATH) 1Q Results—Clearing a Lower Bar
$ULTA 20250529-Wells Fargo-Ulta Beauty, Inc. (ULTA) Solid 1Q Results w Conservative FY Plan Embedded; Rai
$VVV 20250529-Wells Fargo-Valvoline, Inc. (VVV) HQ Visit Takes; Competitive Advantages on Display with L
$ZS 20250529-Wells Fargo-Zscaler, Inc. (ZS) Solid 3Q25 Results as Zscaler Pivots Toward a Platform; Rai
$MRK 20250531-Jefferies-Merck (MRK) MRK: Thoughts on Sac_TMT 1L TNBC Data at ASCO
$IMTX 20250601-Jefferies-Immatics N.V.  (IMTX) PRAME TCRT Shows Con't (+) Data in Melanoma; More Mel + So
$AAPL 20250602-Evercore ISI-Apple Inc (AAPL) EVR Monthly App Store Update No Sign of Impact From Epic Rul
$BNTX 20250602-Evercore ISI-BioNTech SE (BNTX) BMY Partnership Looks Attractive on Multiple Fronts
$CAH 20250602-Evercore ISI-Cardinal Health (CAH) Investor Day Preview_ 12_14% EPS CAGR Continues wPharma
$CDW 20250602-Evercore ISI-CDW Corporation (CDW) Thinking Through WSJ Article of Fed Risk. Stock Reactio
$EXAS 20250602-Evercore ISI-Exact Sciences Corporation (EXAS) Our thoughts on NCCN update of CRC screenin
$NVCR 20250602-Evercore ISI-NovoCure Limited (NVCR) PANOVA_3 ppt at ASCO looks clean…should be set stage 
$SNOW 20250602-Evercore ISI-Snowflake, Inc.  (SNOW)  (SNOW)  Thoughts Into Snowflake Summit & A_Day
$VERA 20250602-Evercore ISI-Vera Therapeutics, Inc (VERA) Ataicept exceeds expectations with 4_handle red
$VRE 20250602-Evercore ISI-Veris Residential Inc (VRE) Showing Tech_Enabled Operating Platform
$WST 20250602-Evercore ISI-West Pharmaceutical Services, Inc (WST) See no readthrough from peer update o
$SAIC 20250602-Jefferies-SAIC (SAIC) Quick Take: Top Line Beat, Profit Miss on Investment wGuide Unchange
$PFE 20250603-Jefferies-Pfizer (PFE) PFE: Thoughts on B6A ADC & potential synergy with PDL1
$ALVO 20250604-Deutsche Bank-Alvotech (ALVO) Post Q1:Waiting for the Northern Lights to reappear
$AMGN 20250604-Deutsche Bank-Amgen (AMGN) Key Takes from June Broker Conference
$RDC 20250604-Deutsche Bank-BRedcare Pharmacy (RDC) Our take on today’s discussion on the CardLink solut
$DSCV 20250604-Deutsche Bank-DiscoverIE Group PLC (DSCV) Margin strength reflected in increased MT targe
$GMAB 20250604-Deutsche Bank-Genmab (GMAB) Hitting the pedal on Rina_S: ASCO review, call takes & further
$HOLN 20250604-Deutsche Bank-Holcim (HOLN) Entering the brave new world_Amrize feedback
$ROG 20250604-Deutsche Bank-Roche (ROG) Diagnostics day feedback
$ENR1n 20250604-Deutsche Bank-Siemens Energy (ENR1n) X catalysts before year end
$VOES 20250604-Deutsche Bank-Voestalpine (VOES) Q4 solid – New capex ceiling supports FCF; Buy
$PIK 20250604-HSBC-Pick n Pay  (PIK) Hold: Revival is an uphill battle
$ASAN 20250604-Jefferies-Asana (ASAN) :Not Enough AI To Offset Real Life Macro
$GILD 20250604-Jefferies-Gilead Sciences, Inc.  (GILD) Takeaways from mgmt dinner _ we remain positive in
$AIR 20250605-CITI-Airbus SE  (AIR)  May Deliveries and First Flights – Lagging Behind (But “Gliders” Ex
$FLYW 20250605-CITI-Flywire Corporation  (FLYW)  Model Update
$OSK 20250605-CITI-Oshkosh Corporation (OSK) Investor Day Takeaways
$RAIL3 20250605-CITI-Rumo SA  (RAIL3)  Deciding to Resign from Its 50% Stake Sale in T39 Terminal
$ATEC 20250606-Barclays-Alphatec Holdings, Inc. (ATEC) Updating Our Estimates, Maintaining Our $XX Price 
$ANET 20250606-Barclays-Arista Networks, Inc. (ANET) ANET NDR Takeaways
$BLCO 20250606-Barclays-Bausch + Lomb (BLCO)  Mgmt ‘Makes It Official,’ Expects to Offset Tariff Impact, 
$BA 20250606-Barclays-Boeing Co. (BA) XXX Dreamlifter Tracker–Three Deliveries So Far in June (Two Japa
$AVGO 20250606-Barclays-Broadcom Inc. (AVGO) Clear Line of Sight
$BFb 20250606-Barclays-Brown_Forman (BFb)  Stoking Structural Debate
$CAN 20250606-Barclays-Canal+ (CAN) A 10% of market cap FCF one_off
$LULU 20250606-Barclays-lululemon athletica inc. (LULU) 1Q25 Review:Reiterate EW as Macro Remains Uncerta
$MCPHY 20250606-Barclays-McPhy Energy SA (MCPHY) Discontinuing Coverage
$MOS 20250606-Barclays-Mosaic (MOS) Lower DAP Volume drives Guidance Revision
$NOVOb 20250606-Barclays-Novo Nordisk (NOVOb) Weekly US diabetes & obesity market tracker
$PVH 20250606-Barclays-PVH Corp. (PVH) 1Q25 Review: Not Yet, But When?
$SGOB 20250606-Barclays-Saint_Gobain (SGOB) Steps towards future progress
$SRPT 20250606-Barclays-Sarepta Therapeutics, Inc (SRPT)  SRPT _ Key Takeaways from Barclays Speaking the
$TNGX 20250606-Barclays-Tango Therapeutics (TNGX) Post ASCO; Previewing Phase X Expansion Data for PRMT5

![](https://pbs.twimg.com/card_img/1935942946735439874/HsTvtDLD?format=jpg&name=800x419)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1937856959992266907/c:line.svg)

**Related Topics**
[vvv](/topic/vvv)
[rai](/topic/rai)
[ulta](/topic/ulta)
[$ulta](/topic/$ulta)
[agilent technologies inc](/topic/agilent-technologies-inc)
[stocks healthcare](/topic/stocks-healthcare)
[$path](/topic/$path)
[ulta beauty inc](/topic/ulta-beauty-inc)

[Post Link](https://x.com/WhatMarketMind/status/1937856959992266907)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

WhatMarketMind Avatar WhatMarketMinds @WhatMarketMind on x 1097 followers Created: 2025-06-25 12:54:37 UTC

$A 20250529-Wells Fargo-Agilent Technologies, Inc (A) Key Takeaways from 2Q25 $PATH 20250529-Wells Fargo-UiPath, Inc (PATH) 1Q Results—Clearing a Lower Bar $ULTA 20250529-Wells Fargo-Ulta Beauty, Inc. (ULTA) Solid 1Q Results w Conservative FY Plan Embedded; Rai $VVV 20250529-Wells Fargo-Valvoline, Inc. (VVV) HQ Visit Takes; Competitive Advantages on Display with L $ZS 20250529-Wells Fargo-Zscaler, Inc. (ZS) Solid 3Q25 Results as Zscaler Pivots Toward a Platform; Rai $MRK 20250531-Jefferies-Merck (MRK) MRK: Thoughts on Sac_TMT 1L TNBC Data at ASCO $IMTX 20250601-Jefferies-Immatics N.V. (IMTX) PRAME TCRT Shows Con't (+) Data in Melanoma; More Mel + So $AAPL 20250602-Evercore ISI-Apple Inc (AAPL) EVR Monthly App Store Update No Sign of Impact From Epic Rul $BNTX 20250602-Evercore ISI-BioNTech SE (BNTX) BMY Partnership Looks Attractive on Multiple Fronts $CAH 20250602-Evercore ISI-Cardinal Health (CAH) Investor Day Preview_ 12_14% EPS CAGR Continues wPharma $CDW 20250602-Evercore ISI-CDW Corporation (CDW) Thinking Through WSJ Article of Fed Risk. Stock Reactio $EXAS 20250602-Evercore ISI-Exact Sciences Corporation (EXAS) Our thoughts on NCCN update of CRC screenin $NVCR 20250602-Evercore ISI-NovoCure Limited (NVCR) PANOVA_3 ppt at ASCO looks clean…should be set stage $SNOW 20250602-Evercore ISI-Snowflake, Inc. (SNOW) (SNOW) Thoughts Into Snowflake Summit & A_Day $VERA 20250602-Evercore ISI-Vera Therapeutics, Inc (VERA) Ataicept exceeds expectations with 4_handle red $VRE 20250602-Evercore ISI-Veris Residential Inc (VRE) Showing Tech_Enabled Operating Platform $WST 20250602-Evercore ISI-West Pharmaceutical Services, Inc (WST) See no readthrough from peer update o $SAIC 20250602-Jefferies-SAIC (SAIC) Quick Take: Top Line Beat, Profit Miss on Investment wGuide Unchange $PFE 20250603-Jefferies-Pfizer (PFE) PFE: Thoughts on B6A ADC & potential synergy with PDL1 $ALVO 20250604-Deutsche Bank-Alvotech (ALVO) Post Q1:Waiting for the Northern Lights to reappear $AMGN 20250604-Deutsche Bank-Amgen (AMGN) Key Takes from June Broker Conference $RDC 20250604-Deutsche Bank-BRedcare Pharmacy (RDC) Our take on today’s discussion on the CardLink solut $DSCV 20250604-Deutsche Bank-DiscoverIE Group PLC (DSCV) Margin strength reflected in increased MT targe $GMAB 20250604-Deutsche Bank-Genmab (GMAB) Hitting the pedal on Rina_S: ASCO review, call takes & further $HOLN 20250604-Deutsche Bank-Holcim (HOLN) Entering the brave new world_Amrize feedback $ROG 20250604-Deutsche Bank-Roche (ROG) Diagnostics day feedback $ENR1n 20250604-Deutsche Bank-Siemens Energy (ENR1n) X catalysts before year end $VOES 20250604-Deutsche Bank-Voestalpine (VOES) Q4 solid – New capex ceiling supports FCF; Buy $PIK 20250604-HSBC-Pick n Pay (PIK) Hold: Revival is an uphill battle $ASAN 20250604-Jefferies-Asana (ASAN) :Not Enough AI To Offset Real Life Macro $GILD 20250604-Jefferies-Gilead Sciences, Inc. (GILD) Takeaways from mgmt dinner _ we remain positive in $AIR 20250605-CITI-Airbus SE (AIR) May Deliveries and First Flights – Lagging Behind (But “Gliders” Ex $FLYW 20250605-CITI-Flywire Corporation (FLYW) Model Update $OSK 20250605-CITI-Oshkosh Corporation (OSK) Investor Day Takeaways $RAIL3 20250605-CITI-Rumo SA (RAIL3) Deciding to Resign from Its 50% Stake Sale in T39 Terminal $ATEC 20250606-Barclays-Alphatec Holdings, Inc. (ATEC) Updating Our Estimates, Maintaining Our $XX Price $ANET 20250606-Barclays-Arista Networks, Inc. (ANET) ANET NDR Takeaways $BLCO 20250606-Barclays-Bausch + Lomb (BLCO) Mgmt ‘Makes It Official,’ Expects to Offset Tariff Impact, $BA 20250606-Barclays-Boeing Co. (BA) XXX Dreamlifter Tracker–Three Deliveries So Far in June (Two Japa $AVGO 20250606-Barclays-Broadcom Inc. (AVGO) Clear Line of Sight $BFb 20250606-Barclays-Brown_Forman (BFb) Stoking Structural Debate $CAN 20250606-Barclays-Canal+ (CAN) A 10% of market cap FCF one_off $LULU 20250606-Barclays-lululemon athletica inc. (LULU) 1Q25 Review:Reiterate EW as Macro Remains Uncerta $MCPHY 20250606-Barclays-McPhy Energy SA (MCPHY) Discontinuing Coverage $MOS 20250606-Barclays-Mosaic (MOS) Lower DAP Volume drives Guidance Revision $NOVOb 20250606-Barclays-Novo Nordisk (NOVOb) Weekly US diabetes & obesity market tracker $PVH 20250606-Barclays-PVH Corp. (PVH) 1Q25 Review: Not Yet, But When? $SGOB 20250606-Barclays-Saint_Gobain (SGOB) Steps towards future progress $SRPT 20250606-Barclays-Sarepta Therapeutics, Inc (SRPT) SRPT _ Key Takeaways from Barclays Speaking the $TNGX 20250606-Barclays-Tango Therapeutics (TNGX) Post ASCO; Previewing Phase X Expansion Data for PRMT5

XXX engagements

Engagements Line Chart

Related Topics vvv rai ulta $ulta agilent technologies inc stocks healthcare $path ulta beauty inc

Post Link

post/tweet::1937856959992266907
/post/tweet::1937856959992266907